AbbVie Inc.ABBVNYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$17.83B
↑ 18% above average
Average (9y)
$15.15B
Historical baseline
Range
High:$24.25B
Low:$6.56B
CAGR
+10.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $17.83B | -19.2% |
| 2023 | $22.06B | -9.0% |
| 2022 | $24.25B | +10.3% |
| 2021 | $21.99B | +31.0% |
| 2020 | $16.79B | +31.5% |
| 2019 | $12.77B | -0.1% |
| 2018 | $12.79B | +35.6% |
| 2017 | $9.43B | +43.7% |
| 2016 | $6.56B | -6.3% |
| 2015 | $7.00B | - |